Day: September 13, 2024

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering […]

Read More

Recent Posts

CEO of APEC Reassures Subscribers on SOBTO Operations

Ouagadougou: The CEO of APEC reassures subscribers about the operation of SOBTO: The Director General of the Agency for the Promotion of Community Entrepreneurship (APEC), Karim Traor, paid a visit to the Burkinabe Tomato Company (SOBTO) in Bobo-Dioul…